Skip to main content

Table 1 Single DNA methylation from liquid biopsy as Biomarkers for lung cancer diagnosis

From: Methylated DNA/RNA in Body Fluids as Biomarkers for Lung Cancer

DNA methylation

Body fluid

Method

Number of cases

Number of controls

Sensitivity (%)/specificity (%) or main findings

References

SHOX2

plasma

qMSP

222

189

60/90

[76]

plasma

qMSP

38

31

80.65/78.57

[46]

DCLK1

plasma

qMSP

65

95

49.2/91.6

[17]

SEPT9

plasma

qMSP

75

100

44.3/92.3

[106]

IEAA

blood

HM450K

43

1986

one unit increase in IEAA was associated with 50% higher risk for LC

[107]

RARβ2

plasma

MSP

52

26

63/51

[50]

csbDNA

MSP

52

26

70/63

[50]

DLEC1

plasma

MSP

78

50

36/98

[85]

CDH1

serum

qMSP

76

30

62/70

[79]

DCC

serum

qMSP

76

30

35.5/100

[79]

CDH13

plasma

MSP

63

36

33/83

[108]

P16

serum

MSP

22

0

14%

[81]

plasma

F-MSP

35

15

40/100

[82]

plasma

modified semi-nested MSP

105

0

73%

[83]

Plasma

F-MSP

30

30

50%

[57]

EBC

F-MSP

30

30

40%

[57]

DAPK

serum

MSP

22

0

18%

[81]

serum

NA

50

0

40%

[80]

GSTP1

serum

MSP

22

0

5%

[81]

MGMT

serum

MSP

22

0

18%

[81]

TMS1

serum

NA

50

0

34%

[80]

RASSFS1A

serum

NA

50

0

34%

[80]

blood cell

NA

NA

NA

positive with LC diagnosis.

[75]

APC

Serum/plasma

MSP

89

50

47%

[84]

LINE-1

csbDNA

MIRA

56

44

AUC0.69

[49]

Buffy coat DNA

PCR pyrosequencing

34

360

Hypomethylation is associated with 3.2-fold higher risk for LC

[51]

p53

peripheral lymphocyte DNA

HpaII quantitative PCR

100

-

Hypomethylation was associated with a 2-fold increased risk for LC

[52]

  1. qMSP quantitative methylation-specific PCR, F-MSP fluorescent methylation-specific PCR, HM450K HumanMethylation450K BeadChip Assay, MSP methylation-specific PCR, MIRA methylated CpG island recovery assay, LC lung cancer, SHOX2 short stature homebox 2, DCLK1 doublecortin like kinase 1, SEPT9 septin9, IEAA intrinsic epigenetic age acceleration, RARβ2 retinoic acid receptor B2, DLEC1 Deleted in lung and esophageal cancer 1, CDH1 cadherin 1, DCC DCC netrin 1 receptor, CDH13 cadherin 13, DAPK death-associated protein kinase, GSTP1 glutathione S-transferase P1, MGMT O6 - methylguanine-DNA-methyltransferase, RASSF1A ras association domain family 1 isoform A, APC adenomatous polyposis coli, p16 cyclin-dependent kinase inhibitor 2A, csbDNA cell-surface-bound circulating DNA, EBC exhaled breath condensate, NA not available